Immuneering Corp - Class A

Penny Stocks Biotech Stocks Healthcare Stocks

$4.48

+0.02 (+0.45%)

As of Sep 20, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -21.0% upside

Low Target $2.50

Average Target $3.54

High Target $3.55

Current Price $4.48

Current
$4.48

Target
$3.54

$2.50 $3.54 avg $3.55

Scenario Analysis

Bear Case

$2.50

-44.2%

Low target

Base Case

$3.54

-21.0%

Avg target

Bull Case

$3.55

+-20.8%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$10.08

-55.6% from high

52-Week Low

$3.86

+16.1% from low

Target vs 52W High

$3.54

-64.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.8%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.3%